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1 Introduction
Although a number of theories have been pro-
posed, the pathogenesis of perinatal brain damage
is still not fully understood. Recently it has been
suggested that perinatal asphyxia is not followed
by neurogenic abnormalities in the infant unless
there is preexisting chronic fetal distress [10]. Hy-
pertensive disease, prolonged pregnancy or intra-
uterine fetal growth retardation are examples of
such conditions. Precise diagnosis and evaluation
of brain injury remain two of the most difficult
problems in the perinatal period. Enzymatic deter-
minations appear promising because damaged
cells may release by-products into body fluids
from which enzymic activities can be detected.
Elevated levels of brain type creatine kinase isoen-
zyme (CK-BB) have been demonstrated in serum
after, either ischemic or traumatic, brain injury in
adults [12, 15]. Other authors have reported the
rise of CK-BB levels in instances of asphyxic insult
[6, 7], intraventricular hemorrhage [19, 20] and
perinatal brain damage in neonates [9].
The purpose of this study is to evaluate the levels
of CK isoenzymes in umbilical cord sera from
newborns who experienced chronic fetal distress
caused by placental dysfunction characterized by
diminished level of human placental lactogen
(HPL) and cystine aminopeptidase (CAP) activity.
We evaluated the clinical state of newborns using
the 5 minutes Apgar score.
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2 Material and methods
Our investigations were performed in a group of
57 newborns delivered after 37 weeks of preg-
nancy. Gestational age was estimated using the
first day of the last menstrual period and by
ultrasonic evaluation. For the study of creatine
kinase activity in umbilical cord sera two groups
of newborns were selected according to placental
function. The first group consisted of infants born
of mothers with normal placental function and
the second group included cases with clinically
suspected placental dysfunction. Two criteria of
placental function were used, i. e. HPL level and
CAP activity as measured in blood sera of preg-
nant women. We examined CAP activity in blood
sera by the method of VAN OUDHEUSDEN [22]
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modified by JOZWIK et al. [11] and the HPL level
was determined using a commercial kit (Organon
Teknika HPL-Nosticon, Elisa system). We have
used the last obtained values prior to the onset of
labor. In our studies we accepted the normal lower
limit of HPL as higher than 5 mg/1 (as determined
and recommended by Organon Teknika, Holland)
and a CAP activity greater than 70 U/l (as deter-
mined in our laboratory). Pregnant patients with
an HPL level and a CAP activity above normal
limits were included into the group of patients
with normal function of the placenta (25 cases,
figure 1). In the remaining cases, placental dys-
function has been suspected.
In an attempt to emphasize placental malfunction
and to make our results relevant and reliable, the
term of placental dysfunction was used in cases
with a simultaneously reduced HPL level and de-
creased CAP activity (21 cases, figure 1). New-
borns blood was drawn from the umbilical cord
at the time of delivery. All blood samples were
centrifuged and sera analyzed immediately or
stored at — 20 °C. Isoenzymes of creatine kinase
were separated by ion exchange column chroma-
tography as described by BONDAR et al. [5]. En-
zymatic activity was measured using kits supplied
by Boehringer-Mannheim (Monotest® CK-NAC
aktiviert). Newborns were considered asphyxiated
with a 5 minutes Apgar score of 7 or less. Of 57
newly born infants, 15 had features of perinatal
asphyxia.
Since enzymatic values were not normally distri-
buted, statistical comparisons were made using a
non-parametric test (S-KendalFs test) [1].
3 Results
Total CK activity in cord sera ranged from 40
to 400 U/l. Isoenzymic distribution for skeletal
muscle type CK (CK-MM) ranged from 17 to
306 U/l, for heart muscle type CK (CK-MB) from
1.8 to 30 U/l and for CK-BB from 4 to 335 U/l.
We were not able to find significant differences in
both total and isoenzymic (CK-MM, CK-MB)
activities of creatine kinase in infants born of
mothers with either normal or impaired placental
function. There were no essential differences in
total CK, CK-MM and CK-MB in either normal
or asphyxiated newborns. Our studies demon-
strated a significant rise of CK-BB activity in cord
sera of newborns delivered from pregnancies with
placental dysfunction (figure 2) as well as in cases
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Figure 2. Histograms of brain type creatine kinase isoen-
zyme (CK-BB) activity in umbilical cord serum of new-
borns in relation to placental function. S-Kendall's test
significant ρ < 0.05.
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Figure 3. Histograms of brain type creatine kinase isoen-
zyme (CK-BB) activity in umbilical cord serum of new-
borns evaluated by 5 minutes Apgar score. S-KendalFs
test significant p < 0.01.
4 Discussion
We found that the main source of total CK enzym-
atic activity in cord blood was derived from the
CK-MM fraction. A few of our cases demon-
strated a higher activity of CK-BB isoenzyme.
During intrauterine hypoxia the fetus is able to
use well known mechanisms of integrated cardio-
vascular response [17]. Since there is impaired
skeletal muscle blood flow during hypoxia, in
cases of placental dysfunction and/or fetal as-
phyxia, we might expect increased release of CK-
MM from skeletal muscles as well as a rise in
total CK activity. In spite of this we were unable
to find a relationship between placental dysfunc-
tion or fetal asphyxia and total CK or CK-MM
activities in cord blood. One possible explanation
is that skeletal muscle is scarcely vulnerable to an
hypoxic state. We realize that any intramuscular
drug injection may result in a CK increase in
blood serum [16]. The second hypothesis is com-
patible with metabolic impairment of skeletal
muscles during fetal hypoxia resulting in CK re-
lease to lymphatic space. LINDENA et al. [14] dem-
onstrated six times higher CK activity in lymph
as compared to serum. Lymph flow is related to
muscle activity. Ischemia is a factor causing a fall
in lymph flow. Other authors have observed the
increase of CK-MM and total CK activity in
blood sera as early as several hours after normal
delivery [2, 7]. It may be correlated with elevated
activity and rise in perfusion of muscles of the
newborn. BODENSTEINER [4] found markedly
higher levels of total CK within 24 hours following
normal vaginal delivery as opposed to cases deli-
vered by cesarean section, suggesting that the
trauma related to natural birth may be responsible
for that phenomenon. We found that newborns
delivered with in utero placental dysfunction and
infants with low Apgar scores have significantly
increased CK-BB activity in cord blood. To date
it is not known if this elevated CK-BB activity
could be considered as a possible indicator of
cerebral injury. During chronic fetal distress in
pregnancies with placental dysfunction, the fetus
utilizes several compensatory mechanisms, but its
ability to survive is handicapped after an acute
episode of hypoxia as compared to cases of nor-
mal uncomplicated pregnancy [3]. Thus, in gesta-
tions affected by placental insufficiency, brain in-
jury is more frequent. Increased CK-BB activity in
this group of newborns may reflect this situation.
Others have confirmed that severe asphyxia re-
sulted in an increase of CK-BB activity in cord
blood [6, 7]. In addition, infants with ominous
fetal heart rate patterns have higher CK-BB activ-
ity [8]. There are several possible sources for CK-
BB activity in cord blood. CK-BB activity in cord
blood could be a result of enzyme loss from pla-
cental tissue. Enzymic activity from placenta was
markedly increased in mild and severe pre-
eclampsia [18]. The human placenta contains only
small amounts of both, total CK and CK-BB;
thus its activities should be small or negligible [6].
CK-BB can also be liberated from the uterus
where it is found in considerable amounts [21].
Umbilical artery and vein contain high CK-BB
activity [13]. BB isoenzyme can come from fetal
lungs and gastrointestinal tract [21]. In spite of
this fact, CUESTAS [7] could not demonstrate an
elevation of this enzyme in neonates with purely
pulmonary or gastrointestinal tract disease. Al-
though different organs do contain CK-BB, the
brain is most likely to represent the source of
elevated CK-BB activity found in cord blood in
cases of placental dysfunction.
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Summary
It has been suggested that perinatal asphyxia is not
generally followed by neurological impairment unless
there is preexisting chronic fetal distress. In cases of
brain damage one can observe elevated levels of CK-
BB. The purpose of our study was to evaluate CK
isoenzymes in umbilical cord blood sera of newborns
affected by chronic fetal distress. Fetal distress reflected
by placental dysfunction was characterized by a dimin-
ished HPL level and decreased activity of CAP. We
estimated CK isoenzymes with the use of DEAE-sepha-
rose CL-6B column chromatography. Total CK activity
was measured using kits supplied by Boehringer-
Mannheim (Monotest® CK-NAC aktiviert). The clinical
state of examined newborns was estimated. Investiga-
tions were carried out in the group of 57 infants delivered
after 37 weeks of gestation. Total CK activity in cord
Keywords: Brain damage, cord blood, creatine kinase isoenzymes, examination, fetal asphyxia, placental dysfunc-
tion.
sera ranged from 40 to 400 U/l. Our results showed a
significant rise of CK-BB activity in cord sera of new-
borns delivered from pregnancies with placental dys-
function (figure 2) as well as in cases of asphyxiated
infants (figure 3). We were unable to demonstrate differ-
ences in total CK, CK-MM and CK-MB activities in
all examined groups of newborns. Other authors have
confirmed that severe asphyxia results in increase in CK-
BB activity in cord blood. Infants with ominous fetal
heart rate patterns have higher CK-BB activity. There
are several possible sources for CK-BB activity in umbil-
ical cord blood sera, i. e. fetal brain, lung, gastrointesti-
nal tract, placenta and uterus. It appears that the brain
is most likely the source of elevated CK-BB activity
found in cord blood in cases of placental dysfunction.
Zusammenfassung
Die Isoenzyme der Semm-Kreatinin-Kinase im Nabel-
schnurblut bei ungenügender Plazenta-Funktion
Es wurde vermutet, daß die perinatale Asphyxie nicht
unbedingt von neurologischen Ausfallerscheinungen ge-
folgt sein muß, gesichert scheint dies nur bei vorherbeste-
henden, chronischen fetalen Dystrophien. In den Fällen,
bei denen ein Gehirnschaden auftrat, konnte ein erhöh-
ter CK-BB-Spiegel gemessen werden. Das Ziel unserer
Studie war die Auswertung der CK-Isoenzyme im Serum
aus Nabelschnurblut Neugeborener, die von chronischer
fetaler Dystrophie in utero betroffen waren. Fetale Dys-
trophie, angezeigt durch plazentare Dysfunktion, war
durch verminderte HPL-Spiegel und verminderte CAP-
Aktivität charakterisiert. Wir schätzten die CK-Isoen-
zyme mit Hilfe der DEAE-Sepharose CL-6B Säulen-
chromatographie, die gesamte CK-Aktivität wurde mit
Boehringer-Mannheim (Monotest® CK-NAC aktiviert)
gemessen. Zusätzlich wurde der klinische Status der
untersuchten Neugeborenen bestimmt. Die Untersu-
chungen wurden in einer Gruppe von 57 Neugeborenen
durchgeführt, die in der 37. Gestationswoche geboren
Schlüsselwörter: Fetale Asphyxie, Gehirnschaden, Isoenzyme der Kreatininkinase, Nabelschnurblutuntersuchung,
plazentare Unterfunktion.
wurden. Die gesamte CK-Aktivität im Nabelserum lag
zwischen 40 und 400 U/l. Unsere Untersuchungen zeig-
ten einen deutlichen Anstieg der CK-BB-Aktivität in
den Nabelschnursera von Neugeborenen aus Schwan-
gerschaften mit einer plazentaren Unterfunktion
(Abb. 2) wie auch in den Fällen von fetaler Asphyxie
(Abb. 3). Wir konnten in allen untersuchten Gruppen
von Neugeborenen keine Unterschiede in den Gesamt-
CK-, den CK-MM- und den CK-MB-Aktivitäten mes-
sen. Andere Autoren bestätigten, daß ausgeprägte
Asphyxie einen Anstieg der CK-BB-Aktivität im Nabel-
schnurblut zur Folge hat. Weiterhin zeigen Neugeborene
mit krankhaften fetalen Herzfrequenzmustern eine er-
höhte CK-BB-Aktivität. Als Ursprung für die CK-BB-
Aktivität im Serum aus Nabelschnurblut kommen meh-
rere Möglichkeiten in Betracht, z. B. das fetale Gehirn,
die Lunge, der Gastrointestinaltrakt, die Plazenta und
der Uterus. Jedoch scheint bei plazentarer Unterfunk-
tion der Ursprung für die erhöhte CK-BB-Aktivität im
Gehirn zu liegen.
Resume
Isoenzymes de la creatine kinase au sang du cordon en
cas de dysfonction placentaire
On a suggere que Fasphyxie perinatale n'entraine pas de
deficit neurologique sauf s'il existe une souffrance foetale
chronique anterieure. En cas de lesions cerebrates, on a
pu observer une elevation des taux de CK-BB. Le but
de notre etude a ete d'evaluer les isoenzymes de la CK
au sang du cordon ombilical chez les nouveaux-nes
ayant presente une souffrance foetale chronique in utero.
La souffrance foetale manifestee par une dysfonction
placentaire est caracterisee par une diminution de l'HPL
et une diminution de Factivite de la CAP. Nous avons
dose les isoenzymes de la CK en utilisant une Chroma-
tographie sur colonne de DEAE-sepharose CL-6B, Fac-
tivite CK totale a ete mesuree en utilisant des kits fournis
par Boehringer-Mannheim (Monotest® CK-NAC akti-
viert). De plus, on a estime Fetat clinique des nouveaux-
nes etudies. Ces explorations ont ete effectuees sur un
groupe de 57 enfants nes apres 37 semaines de gestation.
Uactivite CK totale varie de 40 a 400 U/l. Nos resultats
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montrent une elevation de l'activite CK-BB au sang du
cordon chez les nouveaux-nes nes apres une grossesse
ayant presente une dysfonction placentaire (figure 2)
mais aussi chez les enfants asphyxiques (figure 3). Nous
ne sommes pas capables de demontrer des differences
de la CK totale, et des activites CK-MM et CK-MB
entre les groupes de nouveaux-nes examines. D'autres
auteurs ont confirme que 1'asphyxie severe entrame une
augmentation de l'activite CK-BB au sang du cordon.
Mots-cles: Asphyxie foetale, dysfonction placentaire, examen au sang du cordon, isoenzymes de la creatine kinase,
lesion cerebrale.
De plus, les enfants avec un aspect inquietant du rythme
cardiaque foetal ont une activite CK-BB plus elevee. II
y a plusieurs sources possibles pour l'activite CK-BB au
sang du cordon, a savoir le cerveau, les poumons, le
tractus gastro-intestinal du foetus, le placenta et Puterus.
Cependant, il semble que le cerveau soit la source la
plus probable de l'activite CK-BB elevee trouvee au sang
du cordon en cas de dysfonction placentaire.
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